{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:36:46Z","timestamp":1790624206102,"version":"4.1.0"},"reference-count":86,"publisher":"Oxford University Press (OUP)","issue":"suppl 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Infect Dis."],"published-print":{"date-parts":[[2015,9,15]]},"DOI":"10.1093\/cid\/civ528","type":"journal-article","created":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T13:19:03Z","timestamp":1440681543000},"page":"S69-S78","source":"Crossref","is-referenced-by-count":180,"title":["Skin and Soft-Tissue Infections: A Critical Review and the Role of Telavancin in Their Treatment"],"prefix":"10.1093","volume":"61","author":[{"given":"Amilcar F.","family":"Cardona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel E.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,8,27]]},"reference":[{"key":"2015082705480068000_61.suppl_2.S69.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2014.02.039"},{"key":"2015082705480068000_61.suppl_2.S69.2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.79a.11044"},{"key":"2015082705480068000_61.suppl_2.S69.3","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2011.034"},{"key":"2015082705480068000_61.suppl_2.S69.4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg466"},{"key":"2015082705480068000_61.suppl_2.S69.5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu444"},{"key":"2015082705480068000_61.suppl_2.S69.6","unstructured":"US. Food and Drug Administration. Guidance for industry. Acute bacterial skin and skin structure infections: developing drugs for treatment. 2013. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM071185.pdf . Accessed 8 February 2015."},{"key":"2015082705480068000_61.suppl_2.S69.7","unstructured":"Centers for Disease Control and Prevention. CDC\/NHSN surveillance definitions for specific types of infections. Available at: http:\/\/www.cdc.gov\/nhsn\/PDFs\/pscManual\/17pscNosInfDef_current.pdf . Accessed 8 February 2015."},{"key":"2015082705480068000_61.suppl_2.S69.8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1155\/2008\/846453","article-title":"Bacterial skin and soft tissue infections in adults: a review of their epidemiology, pathogenesis, diagnosis, treatment and site of care","volume":"19","author":"Ki","year":"2008","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2015082705480068000_61.suppl_2.S69.9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-252"},{"key":"2015082705480068000_61.suppl_2.S69.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70191-2"},{"key":"2015082705480068000_61.suppl_2.S69.11","doi-asserted-by":"publisher","DOI":"10.3201\/eid1509.081228"},{"key":"2015082705480068000_61.suppl_2.S69.12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-296"},{"key":"2015082705480068000_61.suppl_2.S69.13","doi-asserted-by":"publisher","DOI":"10.1086\/664048"},{"key":"2015082705480068000_61.suppl_2.S69.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2014.11.006"},{"key":"2015082705480068000_61.suppl_2.S69.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2009.07.050"},{"key":"2015082705480068000_61.suppl_2.S69.16","unstructured":"Centers for Disease Control and Prevention. National hospital discharge survey, 2010. Available at: ftp:\/\/ftp.cdc.gov\/pub\/Health_Statistics\/NCHS\/Dataset_Documentation\/NHDS\/NHDS_2010_Documentation.pdf . Accessed 10 February 2015."},{"key":"2015082705480068000_61.suppl_2.S69.17","doi-asserted-by":"publisher","DOI":"10.1086\/662016"},{"key":"2015082705480068000_61.suppl_2.S69.18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/003335490712200205","article-title":"Estimating health care-associated infections and deaths in U.S. hospitals, 2002","volume":"122","author":"Klevens","year":"2007","journal-title":"Public Health Rep"},{"key":"2015082705480068000_61.suppl_2.S69.19","unstructured":"Centers for Disease Control and Prevention. CDC surgical site infection (SSI) event. 2015. Available at: http:\/\/www.cdc.gov\/nhsn\/PDFs\/pscManual\/9pscSSIcurrent.pdf. Accessed 5 July 2015."},{"key":"2015082705480068000_61.suppl_2.S69.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306801"},{"key":"2015082705480068000_61.suppl_2.S69.21","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31822c6929"},{"key":"2015082705480068000_61.suppl_2.S69.22","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2010.249"},{"key":"2015082705480068000_61.suppl_2.S69.23","doi-asserted-by":"publisher","DOI":"10.1086\/591064"},{"key":"2015082705480068000_61.suppl_2.S69.24","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2003.212"},{"key":"2015082705480068000_61.suppl_2.S69.25","unstructured":"Baddour LM. Cellulitis and erysipelas. Available at: http:\/\/www.uptodate.com\/contents\/cellulitis-and-erysipelas?source=preview&search=cellulitis&language=en-US&anchor=H1&selectedTitle=1~150#H1. Accessed 1 June 2015."},{"key":"2015082705480068000_61.suppl_2.S69.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7198.1591"},{"key":"2015082705480068000_61.suppl_2.S69.27","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.5.1162"},{"key":"2015082705480068000_61.suppl_2.S69.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(02)00017-X"},{"key":"2015082705480068000_61.suppl_2.S69.29","doi-asserted-by":"publisher","DOI":"10.1086\/320879"},{"key":"2015082705480068000_61.suppl_2.S69.30","first-page":"381","article-title":"Soft tissue infections among injection drug users\u2014San Francisco, California, 1996\u20132000","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2015082705480068000_61.suppl_2.S69.31","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.13-5-511"},{"key":"2015082705480068000_61.suppl_2.S69.32","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.2.510"},{"key":"2015082705480068000_61.suppl_2.S69.33","doi-asserted-by":"publisher","DOI":"10.1086\/431587"},{"key":"2015082705480068000_61.suppl_2.S69.34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060057"},{"key":"2015082705480068000_61.suppl_2.S69.35","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2008.066.supp"},{"key":"2015082705480068000_61.suppl_2.S69.36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181e8d635"},{"key":"2015082705480068000_61.suppl_2.S69.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.02.020"},{"key":"2015082705480068000_61.suppl_2.S69.38","doi-asserted-by":"publisher","DOI":"10.1086\/656431"},{"key":"2015082705480068000_61.suppl_2.S69.39","doi-asserted-by":"publisher","DOI":"10.1086\/520743"},{"key":"2015082705480068000_61.suppl_2.S69.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2006.05.009"},{"key":"2015082705480068000_61.suppl_2.S69.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(02)00543-6"},{"key":"2015082705480068000_61.suppl_2.S69.42","doi-asserted-by":"publisher","DOI":"10.1086\/648083"},{"key":"2015082705480068000_61.suppl_2.S69.43","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq252"},{"key":"2015082705480068000_61.suppl_2.S69.44","unstructured":"Sader HS , Flamm RK , Jones RN . Antimicrobial activity of ceftaroline tested against 10,956 organisms causing acute bacterial skin and skin structure infections in the United States medical centers [poster C2\u20131628]. In: 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, CO: 10\u201313 September 2013."},{"key":"2015082705480068000_61.suppl_2.S69.45","doi-asserted-by":"publisher","DOI":"10.1086\/520731"},{"key":"2015082705480068000_61.suppl_2.S69.46","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363140-00003"},{"key":"2015082705480068000_61.suppl_2.S69.47","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-5-200603070-00005"},{"key":"2015082705480068000_61.suppl_2.S69.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2007.07.016"},{"key":"2015082705480068000_61.suppl_2.S69.49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055356"},{"key":"2015082705480068000_61.suppl_2.S69.50","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05817-11"},{"key":"2015082705480068000_61.suppl_2.S69.51","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2008.9955"},{"key":"2015082705480068000_61.suppl_2.S69.52","unstructured":"Stevens DL, Baddour LM . Necrotizing soft tissue infections. Available at: http:\/\/www.uptodate.com\/contents\/necrotizing-soft-tissue-infections?source=preview&search=necrotizing+fasciitis&language=e . http:\/\/www.uptodate.com\/contents\/necrotizing-soft-tissue-infections?source=preview&search=necrotizing+fasciitis&language=en-US&anchor=H1&selectedTitle=1~91#H8 . Accessed 11 February 2015."},{"key":"2015082705480068000_61.suppl_2.S69.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2011.09.001"},{"key":"2015082705480068000_61.suppl_2.S69.54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601253340407"},{"key":"2015082705480068000_61.suppl_2.S69.55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198907063210101"},{"key":"2015082705480068000_61.suppl_2.S69.56","doi-asserted-by":"publisher","DOI":"10.1086\/519936"},{"key":"2015082705480068000_61.suppl_2.S69.57","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00160-5"},{"key":"2015082705480068000_61.suppl_2.S69.58","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.140.2.151"},{"key":"2015082705480068000_61.suppl_2.S69.59","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e318220d7fa"},{"key":"2015082705480068000_61.suppl_2.S69.60","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.2106\/00004623-200308000-00005","article-title":"Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality","volume":"85-A","author":"Wong","year":"2003","journal-title":"J Bone Joint Surg Am"},{"key":"2015082705480068000_61.suppl_2.S69.61","doi-asserted-by":"publisher","DOI":"10.3201\/eid0103.950301"},{"key":"2015082705480068000_61.suppl_2.S69.62","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(02)01411-3"},{"key":"2015082705480068000_61.suppl_2.S69.63","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2009.012"},{"key":"2015082705480068000_61.suppl_2.S69.64","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq146"},{"key":"2015082705480068000_61.suppl_2.S69.65","doi-asserted-by":"publisher","DOI":"10.1086\/526444"},{"key":"2015082705480068000_61.suppl_2.S69.66","first-page":"87","article-title":"Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections","volume":"4","author":"Jafari Saraf","year":"2011","journal-title":"Infect Drug Resist"},{"key":"2015082705480068000_61.suppl_2.S69.67","first-page":"151","article-title":"Methicillin-resistant Staphylococcus aureus infections","volume":"16","author":"Bartlett","year":"2008","journal-title":"Top HIV Med"},{"key":"2015082705480068000_61.suppl_2.S69.68","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm465"},{"key":"2015082705480068000_61.suppl_2.S69.69","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01388-06"},{"key":"2015082705480068000_61.suppl_2.S69.70","doi-asserted-by":"publisher","DOI":"10.1086\/513203"},{"key":"2015082705480068000_61.suppl_2.S69.71","doi-asserted-by":"publisher","DOI":"10.4065\/80.9.1201"},{"key":"2015082705480068000_61.suppl_2.S69.72","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(85)80727-7"},{"key":"2015082705480068000_61.suppl_2.S69.73","doi-asserted-by":"publisher","DOI":"10.1080\/00365540802441711"},{"key":"2015082705480068000_61.suppl_2.S69.74","doi-asserted-by":"publisher","DOI":"10.1086\/426894"},{"key":"2015082705480068000_61.suppl_2.S69.75","doi-asserted-by":"publisher","DOI":"10.1592\/phco.30.1.80"},{"key":"2015082705480068000_61.suppl_2.S69.76","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2200"},{"key":"2015082705480068000_61.suppl_2.S69.77","first-page":"201","article-title":"Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection","volume":"9","author":"Parish","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"2015082705480068000_61.suppl_2.S69.78","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L016"},{"key":"2015082705480068000_61.suppl_2.S69.79","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00859-08"},{"key":"2015082705480068000_61.suppl_2.S69.80","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl403"},{"key":"2015082705480068000_61.suppl_2.S69.81","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn242"},{"key":"2015082705480068000_61.suppl_2.S69.82","doi-asserted-by":"publisher","DOI":"10.1086\/587896"},{"key":"2015082705480068000_61.suppl_2.S69.83","unstructured":"Health Canada. PrVibativ\u00ae 2010. Available at: http:\/\/www.hc-sc.gc.ca\/dhp-mps\/alt_formats\/pdf\/prodpharma\/sbd-smd\/phase1-decision\/drug-med\/sbd_smd_2010_vibativ_107792-eng.pdf . Accessed 19 March 2015."},{"key":"2015082705480068000_61.suppl_2.S69.84","unstructured":"VIBATIV (telavancin) Prescribing Information. Theravance Biopharma Antibiotics, Inc. December 2014. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/022110s011lbl.pdf . Accessed 9 March 2015."},{"key":"2015082705480068000_61.suppl_2.S69.85","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2008.05.012"},{"key":"2015082705480068000_61.suppl_2.S69.86","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2014.12.011"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/61\/suppl_2\/S69\/1114575\/civ528.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T22:16:39Z","timestamp":1567116999000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/civ528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,27]]},"references-count":86,"journal-issue":{"issue":"suppl 2","published-online":{"date-parts":[[2015,8,27]]},"published-print":{"date-parts":[[2015,9,15]]}},"alternative-id":["10.1093\/cid\/civ528"],"URL":"https:\/\/doi.org\/10.1093\/cid\/civ528","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,27]]}}}